Advertisement
Screener

LISATA THERAPEUTICS, INC. (LSTA) Selling, General and Administrative Expense

2.8 / 5 stars · 68/120 Roast Me

LISATA THERAPEUTICS, INC. Selling, General and Administrative Expense

LISATA THERAPEUTICS, INC. (LSTA) reported Selling, General and Administrative Expense of $2.46 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-11-06

  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.46M, a 12.13% decline year-over-year.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $2.69M, a 8.11% decline year-over-year.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $3.25M, a 3.42% decline year-over-year.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $2.79M, a 8.13% increase year-over-year.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2023 was $12.97M, a 8.25% decline from fiscal 2022.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2022 was $14.14M, a 23.24% increase from fiscal 2021.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2021 was $11.47M, a 15.99% increase from fiscal 2020.
  • LISATA THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2020 was $9.89M, a 6.42% increase from fiscal 2019.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 3 month as first filedSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 6 month as first filedSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 9 month as first filedSelling, General and Administrative Expense 12 monthSelling, General and Administrative Expense 12 month as first filed
2025-09-30$2.46M
10-Q · filed 2025-11-06
$5.14M
derived: sum of 2 quarters · filed 2025-11-06
$8.38M
10-Q · filed 2025-11-06
2025-06-30$2.69M
10-Q · filed 2025-08-07
$5.93M
10-Q · filed 2025-08-07
2025-03-31$3.25M
10-Q · filed 2025-05-08
2024-09-30$2.79M
10-Q · filed 2025-11-06
$5.72M
derived: sum of 2 quarters · filed 2025-11-06
$9.08M
10-Q · filed 2025-11-06
$12.09M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$2.92M
10-Q · filed 2025-08-07
$6.28M
10-Q · filed 2025-08-07
$9.29M
derived: sum of 3 quarters · filed 2025-08-07
$11.88M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$3.36M
10-Q · filed 2025-05-08
$6.37M
derived: sum of 2 quarters · filed 2025-05-08
$8.96M
derived: sum of 3 quarters · filed 2025-05-08
$12.67M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$5.60M
derived: sum of 2 quarters · filed 2024-11-12
$9.31M
derived: sum of 3 quarters · filed 2024-11-12
$12.97M
10-K · filed 2024-02-29
2023-09-30$2.58M
10-Q · filed 2024-11-12
$6.30M
derived: sum of 2 quarters · filed 2024-11-12
$9.96M
10-Q · filed 2024-11-12
$13.29M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$3.71M
10-Q · filed 2024-08-12
$7.38M
10-Q · filed 2024-08-12
$10.70M
derived: sum of 3 quarters · filed 2024-08-12
$14.70M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$3.67M
10-Q · filed 2024-05-09
$6.99M
derived: sum of 2 quarters · filed 2024-05-09
$10.98M
derived: sum of 3 quarters · filed 2024-05-09
$14.47M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$7.32M
derived: sum of 2 quarters · filed 2024-02-29
$10.80M
derived: sum of 3 quarters · filed 2024-02-29
$14.14M
10-K · filed 2024-02-29
2022-09-30$3.99M
10-Q · filed 2023-11-02
$3.95M
10-Q · filed 2022-11-10
$7.48M
derived: sum of 2 quarters · filed 2023-11-02
$10.81M
10-Q · filed 2023-11-02
$10.77M
10-Q · filed 2022-11-10
$13.62M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$3.49M
10-Q · filed 2023-08-14
$3.48M
10-Q · filed 2022-08-04
$6.82M
10-Q · filed 2023-08-14
$6.82M
10-Q · filed 2022-08-04
$9.63M
derived: sum of 3 quarters · filed 2023-08-14
$12.47M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$3.34M
10-Q · filed 2023-05-09
$3.34M
10-Q · filed 2022-05-05
$6.14M
derived: sum of 2 quarters · filed 2023-05-09
$8.98M
derived: sum of 3 quarters · filed 2023-05-09
$11.80M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$5.65M
derived: sum of 2 quarters · filed 2023-03-30
$8.46M
derived: sum of 3 quarters · filed 2023-03-30
$11.47M
10-K · filed 2023-03-30
$11.37M
10-K · filed 2022-03-22
2021-09-30$2.84M
10-Q · filed 2022-11-10
$5.66M
derived: sum of 2 quarters · filed 2022-11-10
$8.67M
10-Q · filed 2022-11-10
$11.21M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$2.82M
10-Q · filed 2022-08-04
$5.83M
10-Q · filed 2022-08-04
$8.37M
derived: sum of 3 quarters · filed 2022-08-04
$10.69M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$3.01M
10-Q · filed 2022-05-05
$5.55M
derived: sum of 2 quarters · filed 2022-05-05
$7.87M
derived: sum of 3 quarters · filed 2022-05-05
$10.34M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
$4.86M
derived: sum of 2 quarters · filed 2022-03-22
$7.33M
derived: sum of 3 quarters · filed 2022-03-22
$9.89M
10-K · filed 2022-03-22
2020-09-30$2.32M
10-Q · filed 2021-11-04
$4.79M
derived: sum of 2 quarters · filed 2021-11-04
$7.35M
10-Q · filed 2021-11-04
$9.67M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$2.47M
10-Q · filed 2021-08-05
$5.03M
10-Q · filed 2021-08-05
$7.35M
derived: sum of 3 quarters · filed 2021-08-05
$9.41M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$2.56M
10-Q · filed 2021-05-06
$4.87M
derived: sum of 2 quarters · filed 2021-05-06
$6.94M
derived: sum of 3 quarters · filed 2021-05-06
$9.30M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$2.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$4.38M
derived: sum of 2 quarters · filed 2021-02-25
$6.74M
derived: sum of 3 quarters · filed 2021-02-25
$9.29M
10-K · filed 2021-02-25
2019-09-30$2.07M
10-Q · filed 2020-11-05
$4.43M
derived: sum of 2 quarters · filed 2020-11-05
$6.98M
10-Q · filed 2020-11-05
$9.27M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$2.36M
10-Q · filed 2020-08-13
$4.91M
10-Q · filed 2020-08-13
$7.20M
derived: sum of 3 quarters · filed 2020-08-13
$9.26M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$2.55M
10-Q · filed 2020-05-07
$4.84M
derived: sum of 2 quarters · filed 2020-05-07
$6.90M
derived: sum of 3 quarters · filed 2020-05-07
$9.05M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$4.35M
derived: sum of 2 quarters · filed 2020-03-05
$6.50M
derived: sum of 3 quarters · filed 2020-03-05
$9.39M
10-K · filed 2020-03-05
2018-09-30$2.06M
10-Q · filed 2019-11-06
$2.06M
10-Q · filed 2018-11-08
$4.21M
derived: sum of 2 quarters · filed 2019-11-06
$7.11M
10-Q · filed 2019-11-06
$7.10M
10-Q · filed 2018-11-08
$9.77M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$2.15M
10-Q · filed 2019-08-08
$2.15M
10-Q · filed 2018-08-09
$5.04M
10-Q · filed 2019-08-08
$5.04M
10-Q · filed 2018-08-09
$7.71M
derived: sum of 3 quarters · filed 2019-08-08
$10.65M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$2.90M
10-Q · filed 2019-05-09
$2.90M
10-Q · filed 2018-05-10
$5.57M
derived: sum of 2 quarters · filed 2019-05-09
$8.51M
derived: sum of 3 quarters · filed 2019-05-09
$11.94M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$5.61M
derived: sum of 2 quarters · filed 2019-03-14
$9.04M
derived: sum of 3 quarters · filed 2019-03-14
$11.75M
10-K · filed 2019-03-14
$11.75M
10-K · filed 2018-03-22
2017-09-30$2.94M
10-Q · filed 2018-11-08
$6.38M
derived: sum of 2 quarters · filed 2018-11-08
$9.08M
10-Q · filed 2018-11-08
$11.37M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$3.43M
10-Q · filed 2018-08-09
$6.14M
10-Q · filed 2018-08-09
$8.43M
derived: sum of 3 quarters · filed 2018-08-09
$11.20M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$2.71M
10-Q · filed 2018-05-10
$5.95M
10-Q · filed 2017-05-15
$5.00M
derived: sum of 2 quarters · filed 2018-05-10
$7.76M
derived: sum of 3 quarters · filed 2018-05-10
$10.68M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
$5.06M
derived: sum of 2 quarters · filed 2018-03-22
$7.98M
derived: sum of 3 quarters · filed 2018-03-22
$12.80M
10-K · filed 2018-03-22
$20.37M
10-K · filed 2017-03-17
2016-09-30$2.77M
10-Q · filed 2017-11-09
$4.94M
10-Q · filed 2016-11-07
$5.69M
derived: sum of 2 quarters · filed 2017-11-09
$10.51M
10-Q · filed 2017-11-09
$16.10M
10-Q · filed 2016-11-07
$17.18M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$2.92M
10-Q · filed 2017-08-10
$4.71M
10-Q · filed 2016-08-09
$7.74M
10-Q · filed 2017-08-10
$11.16M
10-Q · filed 2016-08-09
$14.41M
derived: sum of 3 quarters · filed 2017-08-10
$19.56M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$6.46M
10-Q · filed 2017-05-15
$11.49M
derived: sum of 2 quarters · filed 2017-05-15
$16.64M
derived: sum of 3 quarters · filed 2017-05-15
$25.38M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$5.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17
$10.18M
derived: sum of 2 quarters · filed 2017-03-17
$18.92M
derived: sum of 3 quarters · filed 2017-03-17
$30.01M
10-K · filed 2017-03-17
2015-09-30$5.15M
10-Q · filed 2016-11-07
$13.88M
derived: sum of 2 quarters · filed 2016-11-07
$24.97M
10-Q · filed 2016-11-07
$31.47M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30$8.74M
10-Q · filed 2016-08-09
$19.82M
10-Q · filed 2016-08-09
$26.32M
derived: sum of 3 quarters · filed 2016-08-09
$34.22M
derived: sum of 4 quarters · filed 2016-08-09
2015-03-31$11.09M
10-Q · filed 2016-05-05
$17.58M
derived: sum of 2 quarters · filed 2016-05-05
$25.48M
derived: sum of 3 quarters · filed 2016-05-05
$32.92M
derived: sum of 4 quarters · filed 2016-05-05
2014-12-31$6.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$14.39M
derived: sum of 2 quarters · filed 2016-03-15
$21.84M
derived: sum of 3 quarters · filed 2016-03-15
$30.81M
10-K · filed 2016-03-15
2014-09-30$7.89M
10-Q · filed 2015-11-05
$15.34M
derived: sum of 2 quarters · filed 2015-11-05
$24.31M
10-Q · filed 2015-11-05
$30.24M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$7.45M
10-Q · filed 2015-08-06
$16.42M
10-Q · filed 2015-08-06
$22.35M
derived: sum of 3 quarters · filed 2016-03-15
$27.90M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$8.97M
10-Q · filed 2015-05-06
$14.90M
derived: sum of 2 quarters · filed 2016-03-15
$20.46M
derived: sum of 3 quarters · filed 2016-03-15
$24.78M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$5.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$11.49M
derived: sum of 2 quarters · filed 2016-03-15
$15.81M
derived: sum of 3 quarters · filed 2016-03-15
$21.61M
10-K · filed 2016-03-15
2013-09-30$5.56M
10-Q · filed 2014-10-30
$9.88M
derived: sum of 2 quarters · filed 2014-10-30
$15.68M
10-Q · filed 2014-10-30
$20.90M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$4.32M
10-Q · filed 2014-08-07
$10.12M
10-Q · filed 2014-08-07
$15.35M
derived: sum of 3 quarters · filed 2015-03-02
$21.29M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$5.80M
10-Q · filed 2014-05-08
$11.02M
derived: sum of 2 quarters · filed 2015-03-02
$16.97M
derived: sum of 3 quarters · filed 2015-03-02
$21.70M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$5.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$11.17M
derived: sum of 2 quarters · filed 2015-03-02
$15.90M
derived: sum of 3 quarters · filed 2015-03-02
$22.32M
10-K · filed 2015-03-02
2012-09-30$5.95M
10-Q · filed 2013-11-07
$10.68M
derived: sum of 2 quarters · filed 2013-11-07
$17.09M
10-Q · filed 2013-11-07
$23.49M
derived: sum of 4 quarters · filed 2013-11-07
2012-06-30$4.73M
10-Q · filed 2013-08-08
$11.15M
10-Q · filed 2013-08-08
$17.54M
derived: sum of 3 quarters · filed 2013-08-08
$23.51M
derived: sum of 4 quarters · filed 2013-08-08
2012-03-31$6.41M
10-Q · filed 2013-05-09
$9.45M
10-Q · filed 2012-05-11
$12.81M
derived: sum of 2 quarters · filed 2013-05-09
$18.78M
derived: sum of 3 quarters · filed 2013-05-09
$27.65M
derived: sum of 4 quarters · filed 2013-05-09
2011-12-31$6.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$12.37M
derived: sum of 2 quarters · filed 2013-03-11
$21.24M
derived: sum of 3 quarters · filed 2013-03-11
$27.69M
10-K · filed 2013-03-11
$41.85M
10-K · filed 2012-03-20
2011-09-30$5.98M
10-Q · filed 2012-11-13
$8.81M
10-Q · filed 2011-11-10
$14.84M
derived: sum of 2 quarters · filed 2012-11-13
$21.29M
10-Q · filed 2012-11-13
$31.83M
10-Q · filed 2011-11-10
$20.51M
derived: sum of 4 quarters · filed 2012-11-13
2011-06-30$8.87M
10-Q · filed 2012-08-14
$12.59M
10-Q · filed 2011-08-12
$15.32M
10-Q · filed 2012-08-14
$23.02M
10-Q · filed 2011-08-12
$14.53M
derived: sum of 3 quarters · filed 2012-08-15
$23.84M
derived: sum of 4 quarters · filed 2012-08-15
2011-03-31$9.63M
10-Q · filed 2012-05-11
$5.66M
derived: sum of 2 quarters · filed 2012-08-15
$14.97M
derived: sum of 3 quarters · filed 2012-08-15
$22.83M
derived: sum of 4 quarters · filed 2012-08-15
2010-12-31-$3.97M
derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15
$5.33M
derived: sum of 2 quarters · filed 2012-08-15
$13.20M
derived: sum of 3 quarters · filed 2012-08-15
$19.47M
8-K · filed 2012-08-15
$30.79M
10-K · filed 2012-03-20
2010-09-30$9.31M
10-Q · filed 2011-11-10
$17.17M
derived: sum of 2 quarters · filed 2011-11-10
$23.44M
10-Q · filed 2011-11-10
2010-06-30$7.87M
10-Q · filed 2011-08-12
$14.15M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
BIOVIE INC. (BIVI)United States$0.012B